RxDoctor Payments Data

Linus Miller, DO

Family Medicine · Mesquite, TXNPI 1689699894

Payments from drug & device makers

$19,199in general payments, 2019–2025

Across 984 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Boehringer Ingelheim$2K
  • GSK$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Lilly USA, LLC$1K
  • plus $10K from 53 others

What the payments were for

  • Consulting fees$1,2006%
  • Food & beverage$17,99894%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk108$1,960
AstraZeneca76$1,619
Boehringer Ingelheim84$1,502
GSK73$1,477
Biohaven Pharmaceuticals, Inc.7$1,245
Lilly USA, LLC86$1,106
Amgen54$1,072
Pfizer74$1,050
Bayer59$977
AbbVie(2 entities)55$898
Dexcom, Inc.16$597
Merck45$566
Idorsia Pharmaceuticals US Inc15$510
Johnson & Johnson32$505
Antares Pharma, Inc.13$429
Esperion Therapeutics, Inc.24$390
Amarin Pharma, Inc.23$377
Astellas Pharma US Inc13$322
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$269
Optinose US, Inc.4$249
Sanofi-aventis U.S. LLC12$196
Exact Sciences8$166
Melinta Therapeutics, LLC3$132
Teva Pharmaceuticals USA, Inc.3$112
Ironwood Pharmaceuticals, Inc6$104
Kowa Pharmaceuticals America, Inc.6$103
Eisai Inc.5$100
Sunovion Pharmaceuticals Inc.6$97
Abbott5$95
Sanofi Pasteur Inc.5$80
Avvisto Therapeutics, LLC4$64
Biohaven Pharmaceutical Holding Company Ltd.4$61
Novartis3$59
Dynavax Technologies Corporation3$55
Phathom Pharmaceuticals, Inc.3$53
Xeris Pharmaceuticals, Inc.3$52
Genentech USA, Inc.3$48
Inspire Medical Systems, Inc.1$43
Intuity Medical Inc3$43
Boston Scientific1$37
Scilex Pharmaceuticals Inc.2$34
Arbor Pharmaceuticals, Inc.2$29
Currax Pharmaceuticals LLC2$27
OPKO Pharmaceuticals, LLC2$25
Edwards Lifesciences1$23
Phadia US Inc.1$23
Acadia Pharmaceuticals Inc1$22
Vivaquant Inc, Dba Rhythm Express2$22
Paratek Pharmaceuticals, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$19
Renalytix AI, Inc.1$19
Biogen1$17
Stryker1$17
Impel Pharmaceuticals Inc.1$16
E.r. Squibb & Sons, L.L.C.1$15
Lifescan, Inc.1$15
Circassia Inc.1$15
Philips North America LLC1$14
Athena Bioscience, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,199 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$43,575
Medicare patients
132
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban128$81,969
MounjaroTirzepatide54$68,951
JardianceEmpagliflozin36$50,154
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$38,031
FarxigaDapagliflozin Propanediol31$36,743
OzempicSemaglutide19$22,361
TrulicityDulaglutide11$20,728
MyrbetriqMirabegron16$16,574
XareltoRivaroxaban18$16,566
LinzessLinaclotide16$11,200
VascepaIcosapent Ethyl24$10,913
Lantus SolostarInsulin Glargine,hum.Rec.Anlog80$7,194
Paroxetine Hcl15$6,485
Atrovent HfaIpratropium Bromide12$5,851
Gabapentin271$4,968

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,106$89,67965 claims
PfizerEliquis$1,050$81,969128 claims
Boehringer IngelheimJardiance$1,502$50,15436 claims
AstraZenecaFarxiga, Symbicort$1,619$40,77348 claims
GSKTrelegy Ellipta$1,477$38,03157 claims
Novo NordiskOzempic$1,960$22,36119 claims
Astellas Pharma US IncMyrbetriq$322$16,57416 claims
Johnson & JohnsonXarelto$505$16,56618 claims
AbbVieLinzess$898$11,20016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Mesquite

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →